by clearskymd | Feb 6, 2020 | Blog
We were delighted to be invited to showcase our technology and devices at a prestigious innovation exchange event in Leeds in January – MIT Reap. The event was part of an international programme that the city of Leeds was chosen to host, in partnership with one...
by clearskymd | Sep 28, 2018 | Blog
ClearSky Medical Diagnostics will be heading to Hong Kong in October for the 22nd International Congress of Parkinson’s Disease and Movement Disorders (MDS). The Congress will bring together world-renowned delegates sharing information on neurodegenerative and...
by clearskymd | Jul 20, 2018 | Blog
ClearSky Medical Diagnostics is proud to be part of an award-winning team that scooped top prize in the Human-Competitive Awards (Humies) 2018 in Japan. The Humies Awards recognise work that has not just solved some problem via techniques from evolutionary computation...
by clearskymd | May 31, 2018 | Blog
Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine. People with Parkinson’s lack enough dopamine because some of the brain cells that make it have died. The loss of...
by clearskymd | Mar 4, 2018 | Blog
ClearSky Medical Diagnostics’ portfolio of non-invasive devices for diagnosing and monitoring neurodegenerative conditions is based on unique biologically-inspired technology. We use a range of standard peripherals, including tablets, sensors, and data gloves, to...
by clearskymd | Feb 24, 2018 | Blog
Complex figure tests are widely used neuropsychological tests where participants are asked to reproduce a complicated line drawing, first by copying it freehand and then drawing it from memory. One such ‘pen and paper’ test is the Rey Osterrieth Figure (ROCF), which...
Recent Comments